TABLE 1.
Receptor subtype | Effect of | ||
---|---|---|---|
Receptor knockout | Agonist | Antagonist | |
5‐HT1A | Inconsistent/= FI and BW 24 , 25 , 26 |
↓ FI (NAc) 30 |
↓ palatable FI 27 |
5‐HT1B | Slightly ↑ FI and BW 25 , 31 | ||
5‐HT2A | = FI and BW 38 |
↓ FI 39 ↑ FI (CeA; via direct 5‐HT2A + neuron activation) 40 |
|
5‐HT2C | ↑ FI and BW 41 , 42 |
↓ FI (POMC neurons/VMN) 36 , 44 , 45 ↓ motivational FI (NAc/VTA; via direct 5‐HT2C + neuron activation) 30 , 46 |
↑ FI 47 |
5‐HT3A | = FI and BW 48 |
= FI 48 ↓ FI [NTS (AgRP‐ablated)] ↓ FI (VTA) 49 ↑ FI (NAc) 49 |
= FI 48 ↓ CCK‐mediated inhibition of gastric emptying 50 ↑ FI (rostral NTS) |
5‐HT4 |
= basal FI 51 ↓ stress‐induced hypophagia 51 |
↓ FI (NAc) 52 | ↑ FI in the fed state (NAc) 53 |
5‐HT6 | ↓ FI and BW on high‐fat diet 54 |
↓ FI and BW 55 ↑ (NAc) 30 |
↓ FI and BW 56 |
5‐HT7 | = BW 57 |
↓ (NAc at higher dose) 30 ↑ (NAc at lower dose) 30 |
Note: Presented are the effects of systemic receptor agonism/antagonism, unless a region is specified.
Abbreviations: 5‐HT, 5‐hydroxytryptamine; AgRP, agouti‐related peptide; BW, body weight; CCK, cholecystokinin; CeA, central nucleus of the amygdala; FI, food intake; NAc, nucleus accumbens; NTS, nucleus tractus solitaries; NPY, neuropeptide Y; PBN, parabrachial nucleus; POMC, proopiomelanocortin; VMN, ventral medial nucleus; VTA, ventral tegmental area.